Overview
Calcium plays a vital role in the anatomy, physiology and biochemistry of organisms and of the cell, particularly in signal transduction pathways. The skeleton acts as a major mineral storage site for the element and releases Ca2+ ions into the bloodstream under controlled conditions. Circulating calcium is either in the free, ionized form or bound to blood proteins such as serum albumin. Although calcium flow to and from the bone is neutral, about 5 mmol is turned over a day. Bone serves as an important storage point for calcium, as it contains 99% of the total body calcium. Low calcium intake may also be a risk factor in the development of osteoporosis. The best-absorbed form of calcium from a pill is a calcium salt like carbonate or phosphate. Calcium gluconate and calcium lactate are absorbed well by pregnant women. Seniors absorb calcium lactate, gluconate and citrate better unless they take their calcium supplement with a full breakfast.
Indication
Calcium plays a vital role in the anatomy, physiology and biochemistry of organisms and of the cell, particularly in signal transduction pathways. It is vital in cell signaling, muscular contractions, bone health, and signalling cascades.
Associated Conditions
- Calcium Deficiency
- Deficiency, Vitamin D
- Osteodystrophy
- Osteomalacia
- Osteoporosis
- Chronic Hypocalcemia
- Chronic Hypocalcemia caused by anticonvulsant medications
Research Report
An Evidence-Based Monograph on Calcium: From Elemental Properties to Clinical Controversies
Section 1: Identification and Physicochemical Profile
This section establishes the fundamental identity of calcium, grounding the subsequent pharmacological and clinical discussion in its basic chemical and physical nature. Calcium, as both a fundamental element and a therapeutic agent, possesses a unique profile that dictates its handling, reactivity, and biological function.
1.1 Nomenclature and Identification
The subject of this monograph is the chemical element Calcium, which is identified in pharmaceutical and chemical databases by a set of unique identifiers. In the DrugBank database, it is classified as a small molecule with the accession number DB01373.[1] The Chemical Abstracts Service (CAS) has assigned it the registration number 7440-70-2, which specifically refers to the elemental form of calcium.[2]
The element is known by several synonyms across different languages and contexts, including "Calcium, elemental," "Elemental calcium," "Calcio" (Spanish), and "Kalzium" (German).[1] In chemical and industrial settings, it is commonly referred to as "Calcium Metal".[4] Its European Community (EC) number is 231-179-5.[2] While the DrugBank entry DB01373 refers to the therapeutic entity, the CAS number 7440-70-2 pertains to the pure element itself. This distinction is important, as the therapeutic applications invariably involve calcium salts rather than the highly reactive elemental metal.
1.2 Atomic and Chemical Properties
Calcium's position in the periodic table defines its chemical behavior. It is an alkaline earth metal, located in Group 2 and Period 4, and belongs to the s-block elements.[9] Its properties are characteristic of the heavier elements in its group, including strontium and barium.[9]
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2025/08/03 | Not Applicable | Not yet recruiting | |||
2025/08/01 | Not Applicable | Recruiting | |||
2025/07/17 | Not Applicable | Not yet recruiting | Minia University | ||
2025/07/09 | Not Applicable | Recruiting | Zhejiang Doer Biologics Co., Ltd. | ||
2025/06/11 | Phase 2 | Not yet recruiting | Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | ||
2025/04/16 | Not Applicable | Recruiting | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | ||
2025/02/12 | Phase 2 | Not yet recruiting | Komal Ashraf Khan | ||
2025/02/04 | Phase 4 | Completed | |||
2025/01/16 | Not Applicable | Completed | |||
2025/01/08 | Not Applicable | Not yet recruiting |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
Avion Pharmaceuticals, LLC | 75854-313 | ORAL | 155 mg in 1 1 | 1/7/2021 | |
Avion Pharmaceuticals, LLC | 75854-312 | ORAL | 155 mg in 1 1 | 1/7/2021 | |
PruGen, Inc. Pharmaceuticals | 42546-300 | ORAL | 124.1 mg in 1 1 | 2/22/2013 | |
Acella Pharmaceuticals, LLC | 42192-321 | ORAL | 140 mg in 1 1 | 1/5/2018 | |
METHOD PHARMACEUTICALS, LLC | 58657-170 | ORAL | 200 mg in 1 1 | 12/10/2023 | |
Avion Pharmaceuticals, LLC | 75854-314 | ORAL | 155 mg in 1 1 | 1/7/2021 | |
Pharmics, Inc. | 0813-0202 | ORAL | 200 mg in 1 1 | 9/6/2012 | |
Bryant Ranch Prepack | 63629-3545 | ORAL | 200 mg in 1 1 | 7/17/2014 | |
Exeltis USA, Inc. | 0642-0079 | ORAL | 100 mg in 1 1 | 12/31/2022 | |
Acella Pharmaceuticals, LLC | 42192-323 | ORAL | 160 mg in 1 1 | 9/11/2018 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
LEUCOVORIN CALCIUM folinic acid (as calcium folinate) 100mg/10mL injection USP | 49312 | Medicine | A | 6/23/1994 | |
DBL LEUCOVORIN CALCIUM folinic acid 15 mg/2mL (as calcium folinate) injection ampoule | 16351 | Medicine | A | 10/8/1991 | |
CALCIUM FOLINATE EBEWE folinic acid (as calcium folinate) 1000 mg/100 mL injection vial | 166260 | Medicine | A | 2/14/2011 | |
InNatal | 346421 | Medicine | A | 10/22/2020 | |
Adrenal Adapt | 444375 | Medicine | A | 3/25/2024 | |
ORGANIC Iron COMPLETE | 372450 | Medicine | A | 8/9/2021 | |
Natal Care | 395834 | Medicine | A | 9/12/2022 | |
Ultra Nature Selancy Men | 407238 | Selima Pharmaceuticals | Medicine | A | 4/3/2023 |
Leucovorin Calcium Injection 50 mg/5 mL (8) | 406772 | Medicine | A | 3/24/2023 | |
Snapshot Activated Folate | 484112 | Medicine | A | 3/26/2025 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
LIQUID CALCIUM MG PHOSPHORUS AND VIT.D-3 | organika health products inc. | 02053675 | Liquid - Oral | 600 MG / 15 ML | 12/31/1993 |
COMPLETE MULTI TAB | gahler enterprises ltd. | 00477354 | Tablet - Oral | 125 MG | 12/31/1979 |
CALCIMAG TAB | les produits naturels suisse inc. | 00555363 | Tablet - Oral | 158 MG / TAB | 12/31/1985 |
SWISS ONE | swiss herbal remedies ltd. | 00579785 | Tablet - Oral | 130 MG | 12/31/1981 |
OSTEO FORMULA | nutramed laboratories inc. | 02239456 | Tablet - Oral | 600 MG | N/A |
CALAMINE LOTION USP | produits marc-o (1987) inc., division of technilab inc. | 00458511 | Lotion - Topical | 54.6 ML / 100 ML | 12/31/1978 |
ANAPLEX TAB | anabolic laboratories inc. | 00299820 | Tablet - Oral | 160 MG / TAB | 12/31/1975 |
FORMULA INF | balance plus, inc. | 02241072 | Capsule - Oral | 125 MG / CAP | 2/9/2000 |
CALCI A AND D TAB | pharmetics (2011) inc | 00479144 | Tablet - Oral | 165 MG | 12/31/1981 |
CALCITOL | frega inc. | 00478830 | Capsule - Oral | 165 MG / CAP | 12/31/1979 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
MASTICAL D 500 MG/1000 UI COMPRIMIDOS MASTICABLES SABOR FRESA | 79937 | COMPRIMIDO MASTICABLE | Medicamento Sujeto A Prescripción Médica | Commercialized | |
ELEVIT COMPRIMIDOS RECUBIERTOS CON PELICULA | Bayer Hispania S.L. | 67267 | COMPRIMIDO RECUBIERTO CON PELÍCULA | Sin Receta | Not Commercialized |
MASTICAL D 500 MG/400 UI COMPRIMIDOS MASTICABLES SABOR FRESA | 79938 | COMPRIMIDO MASTICABLE | Medicamento Sujeto A Prescripción Médica | Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.